BSEBoard Meeting6d ago · 9 Aug 2026, 05:09 pm
Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Update on board meeting 1. ....
Natural Capsules Ltd · 524654
✦ AI SummaryFundraise
Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the unaudited consolidated & standalone financial results for the quarter ended June 30, 2026, and also to evaluate a proposal for raising funds by way of issue of equity shares, convertibles, and/or any other eligible securities on a preferential basis.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk3/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natural Capsules Ltd - 524654 - Update on board meeting
Attachments (1)
📄pdf
Download →
431bee30-82eb-40c5-b139-6978ebaf3b36.pdf
View document text
A C C R E D I T E D
ISO/IEC 17021
CERTIFICATION BODY
Date: August 09, 2026
To To
BSE Limited National Stock Exchange of India Limited
25th Floor, PJ Towers Exchange Plaza, C-1, Block G
Dalal Street, Bandra Kurla Complex, Bandra (E)
Mumbai – 400001 Mumbai – 400051
Scrip Code: 524654 Symbol: NATCAPSUQ
Sub: In addition to intimation for Board Meeting dated August 4, 2026 – Addition to Agenda regarding Board
Meeting scheduled on Wednesday August 12, 2026,
Dear Sir / Madam,
Further to our intimation dated August 4, 2026 informing the Exchange(s) about the Board Meeting Scheduled to be
held on Wednesday August 12, 2026, inter alia, to consider and approve the Unaudited Consolidated & Standalone
Financial Results for the quarter ended June 30, 2026, we wish to further inform that the Board of Directors will, at the
said meeting, also consider the following additional item of business:
1. Evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible
securities, on a preferential basis, subject to all such regulatory / statutory approvals as may be required
including the approval of shareholders of the Company.
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for
prevention of Insider Trading and Code of Corporate Disclosure Practices, We wish to inform you that the “Trading
Window” for dealing in the Equity Shares of the Company has remained closed for all Designated Person and their
Immediate Relatives w.e.f. July 01, 2026 till the conclusion of 48 hours after the declaration of Financial Results of the
Company for the Quarter ended June 30, 2026.
Yours Faithfully,
For Natural Capsules Limited
Akshay Dutta
Company Secretary and Compliance Officer
M.No. A80481